ABSTRACT
INTRODUCTION
In this edition of the Journal, we release the twelfth in a series of reviews of influential articles that have been previously published in ACC journals, including the American Journal of Cardiology (from 1958 to 1982) and JACC (from 1983 to the present). The publication of these articles is only one aspect of the ACC's 50th anniversary commemoration, which highlights 50 years of leadership in cardiovascular care and education. The articles are intended to encourage reflection on the remarkable progress made in cardiovascular medicine over time, as well as to acknowledge the amazing prescience of some early investigators in anticipating and, in many cases, later guiding developments in their field.
The working group responsible for selecting these articles and asking reviewers to write editorials solicited suggestions from the ACC's clinical committees and individual members.
The group achieved consensus fairly easily, including whom the group should ask to prepare the accompanying editorials. We initially drew up a list of 14 general areas to cover in this series, but later found that there are several major areas of modern cardiology, prominently molecular cardiology, in which the truly landmark articles have, alas, not yet been published in JACC. Therefore, the working group decided not to categorize by subject, but instead, to concentrate on the most important articles.
I joined the team led by Stanley J. Sarnoff in the Laboratory of Cardiovascular Physiology at the (then) National Heart Institute to investigate the hemodynamic determinants of this critical variable. The importance of MV O 2 had been appreciated since the work of Evans and Matsuoko (2) in Ernest Starling's laboratory at the beginning of the 20th century. These investigators understood that the heart is an aerobic organ and cannot (except for very brief periods) develop an oxygen debt. However, there had been surprisingly little research on this important aspect of cardiovascular physiology for four decades, and we felt that if we could "get a handle on" the determinants of MV O 2 , we would gain important insights into the heart's total metabolic activity and could then relate this to its contractile function.
Our first task was to develop a canine heart preparation in which the key hemodynamic parameters (preload, afterload and heart rate) could be accurately measured and independently controlled. In the classical heart-lung preparation, heart failure is progressive, but we needed to maintain normal cardiac function over several hours. This would avoid the confounding influence of progressive reductions of contractility and of ventricular dilation on the relation between cardiac contraction and energetics. Therefore, in our "isolated supported heart preparation," we used a separate support dog whose circulation was in series with the isolated heart and whose lungs served to oxygenate the blood (3). The idea for this preparation had been sparked by the technique of controlled cross circulation, which allowed open-heart surgery to be performed before the perfection of the heart-lung machine.
These experiments were both complex and costly; they involved the use of a new generation of flow meters that provided simultaneous and precise measurement of cardiac output and coronary blood flow. Each experiment took a team of eight investigators, post docs and technicians about 18 h, and the manual analysis of the records produced by the first eight-channel recorder used in cardiovascular physiology took us another week or so.
From this study we learned that at any heart rate, intraventricular pressure was the most important determinant of MV O 2 . The area under the left intraventricular pressure curve, which we termed the "tension-time index," proved to be an even better correlate of MV O 2 than the peak pressure itself because this area takes account of the important effects of heart rate and the relatively modest effects of stroke volume (4) . Having established the tensiontime index as a major determinant of MV O 2 , we went on to demonstrate that MV O 2 , in turn, is the major determinant of coronary blood flow (5) . Subsequently, other investigators devised techniques for calculating ventricular wall tension, an even closer correlate of MV O 2 than the tension-time index (6). 
Control of Myocardial

Review
A decade later, I resumed studies of this subject with new collaborators-John Ross, Edmund Sonnenblick, James Covell, Neal Coleman, Tom Graham and others. In the interim, principles of skeletal muscle mechanics had been adapted to the heart. A second set of experiments was carried out using a new canine preparation. With the dog on total cardiopulmonary bypass, a balloon was placed into the left ventricle so that it contracted isometrically; myocardial contractility was defined as the maximal velocity of calculated contractile element shortening, the so-called Vmax (8) . We demonstrated the importance of myocardial contractility as the third key determinant of MV O 2 (9,10) and then extended our work to the isolated papillary muscle, which allowed more precise measurement of myocardial shortening (11) . From this work and the work of other investigators, we defined nine determinants of MV O 2 -the "big three" (systolic wall tension, contractility and heart rate) and six others (Table 1) . These experiments were then extended to dogs with experimentally-produced and quantified valvular regurgitation (12) .
An understanding of the determinants of MV O 2 clarified a number of previously puzzling clinical observations. For example, the reduced levels of systolic wall tension in mitral regurgitation explained the infrequency of ischemic manifestations in patients with this valvular abnormality. The rarity of angina in patients with idiopathic dilated cardiomyopathy and severe heart failure-despite the increase in left ventricular volume and, therefore, in wall tensioncould be explained by the diminished myocardial contractility. A reduction of MV O 2 through slowing of heart rate and blockade of the stimulant effects of sympathetic influences on myocardial contractility was responsible for the anti-anginal actions of the beta-adrenoreceptor blockers when they were introduced. The reduction of MV O 2 through a lowering of systolic intraventricular pressure (and wall tension) explained, in part, the benefit of the recently developed technique of intra-aortic balloon counterpulsation in some patients with acute myocardial ischemia.
The work of Suga (13) represents a major development since the publication of these two papers in the American Journal of Cardiology (the forerunner of the Journal of the American College of Cardiology). This investigator found that the left ventricular pressure-volume area (PVA) (i.e., the area subtended by the left ventricular pressure-volume curve) correlates even more closely with MV O 2 than do other variables. More recently, the PVA has been measured in humans from left ventricular pressure-volume loops (14, 15) . The imputed MV O 2 at a PVA of zero is considered to be the oxygen cost of excitation-contraction coupling; it increases with the administration of beta adrenergic agonists and decreases with impaired myocardial contractility (15).
Perhaps of greatest importance to me was that these studies on MV O 2 led my colleagues and me to attempt to limit myocardial infarct size following coronary occlusion. As stated in the 1971 paper: ". . . An understanding of the determinants of myocardial oxygen consumption is particularly relevant to patients with acute myocardial infarction . . . Since the blood supply to (the) ischemic segment of myocardium is markedly reduced, its survival may depend on its oxygen needs. If the oxygen requirement of the myocardium is stimulated by factors such as increased tension, or contractility, or both, the viability of the ischemic area may be reduced and the size of the infarct enlarged . . . "To test this hypothesis, branches of the left anterior descending coronary artery were ligated in the open chest dog and epicardial leads were recorded over the anterior surface of the left ventricle before and after the occlusion. Areas of ischemia, i.e., with elevations of the ST segment, were observed in the direct distribution of the occluded vessel . . . The augmentation of myocardial oxygen consumption produced by stimulating myocardial contractility with the administrations of positive inotropic agents such as isoproterenol caused further elevation of ST segments . . . Conversely, the administration of a beta adrenergic blocking drug, propranolol, which blocks the stimulating effects of adrenergic agents on the heart, would be expected to lower myocardial oxygen demands, and in these studies it was found to reduce the ST-segment elevations occurring during coronary occlusion. It was of considerable interest that changes in myocardial oxygen consumption produced as late as 3 hours after coronary occlusion altered the area of ischemic injury. (my current emphasis) . . . "Reduction of myocardial oxygen demands produced by slowing the heart rate and counteracting the augmentation of sympathetic influences may reduce oxygen demands and thereby the size of the infarction." (my current emphasis)
These observations led to a long string of experiments in the dog and rat, conducted first with the late Peter Maroko and subsequently with James Muller and Robert Kloner, in which a variety of interventions-including myocardial reperfusion-were shown to be effective in limiting myocardial damage following coronary occlusion (16) . These experiments, in turn, led to our efforts in the TIMI (Thrombolysis in Myocardial Infarction) trials to improve clinical outcome with thrombolytic therapy early in the course of myocardial infarction (17) .
In 1955, when we began our work on elucidating the determinants of MV O 2 , we did not appreciate its potential clinical relevance. At that time, our experiments were categorized as basic physiologic research, of little if any clinical import. Their potential clinical significance became clear only after a latent period of about 15 years (55 years if we take as the starting point the 1915 experiments of Evans and Matsuoko [2] referred to previously). It is gratifying to me that we now live in an era in which there is great encouragement for investigators to accelerate "bench to bedside" translation. 
